BlackRock Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $22.7M | Buy |
889,177
+236,982
| +36% | +$6.05M | 0.02% | 493 |
|
|
2016
Q3 | $23.6M | Buy |
652,195
+3,278
| +0.5% | +$119K | 0.02% | 452 |
|
|
2016
Q2 | $22.1M | Sell |
648,917
-26,292
| -4% | -$893K | 0.02% | 487 |
|
|
2016
Q1 | $17.8M | Buy |
675,209
+166,393
| +33% | +$4.39M | 0.02% | 562 |
|
|
2015
Q4 | $24.8M | Sell |
508,816
-673
| -0.1% | -$32.8K | 0.03% | 473 |
|
|
2015
Q3 | $12.7M | Buy |
509,489
+12,972
| +3% | +$323K | 0.01% | 678 |
|
|
2015
Q2 | $15.7M | Buy |
496,517
+28,541
| +6% | +$903K | 0.02% | 603 |
|
|
2015
Q1 | $17.8M | Buy |
467,976
+26,351
| +6% | +$1M | 0.02% | 586 |
|
|
2014
Q4 | $17.2M | Buy |
441,625
+229,088
| +108% | +$8.92M | 0.02% | 593 |
|
|
2014
Q3 | $6.43M | Sell |
212,537
-24,206
| -10% | -$732K | 0.01% | 891 |
|
|
2014
Q2 | $8.04M | Buy |
236,743
+7,824
| +3% | +$266K | 0.01% | 826 |
|
|
2014
Q1 | $7.9M | Buy |
228,919
+19,773
| +9% | +$682K | 0.01% | 851 |
|
|
2013
Q4 | $8.28M | Buy |
+209,146
| New | +$8.28M | 0.01% | 830 |
|